NCT01334996
- Conditions
- Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +6 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Mast Cell Activation Disorders
Explore clinical trials studying Mast Cell Activation Disorders. Study availability and eligibility vary by location and protocol.
93 public trials
18 recruiting studies
Mast Cell Activation Disorders trial results
NCT03406325
- Conditions
- Anaphylaxis, Asthma, Bronchial Diseases, +29 more
- Locations
-
- Hong Kong Sanatorium & Hospital Hong Kong
NCT00014235
- Conditions
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Conditions
- Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
NCT00050193
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +18 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00814073
- Conditions
- Albinism, Amino Acid Metabolism, Inborn Errors, Behavior, +28 more
- Locations
-
- UC Davis Health System , Department of Dermatology Sacramento, California, United States
- MD Anderson Cancer Centre Houston, Texas, United States
- CHU d'Amiens Amiens, France
- Hôpital Avicenne Bobigny, France
NCT02503800
- Conditions
- Bites and Stings, Chemically-Induced Disorders, Hypersensitivity, +11 more
- Locations
-
- Meir Medical Center Kfar Saba, Israel
NCT03632811
- Conditions
- Cutaneous Mastocytosis, Immune System Diseases, Indolent Systemic Mastocytosis, +12 more
- Locations
-
- University Hospital Toulouse Toulouse, France
NCT02441166
- Conditions
- Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +11 more
- Locations
-
- CHU Bordeaux Hôpital Haut-Lévêque, service de dermatologie Bordeaux, France
- CHU de Caen, service d'hématologie Caen, France
- CHU Dupuytren service d'hématologie Limoges, France
- CHU Lyon Sud, service de médecine interne Lyon, France
Completed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002
NCT02808793
- Conditions
- Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +6 more
- Locations
-
- Charité - Universitätsmedizin Berlin Berlin, Germany